Cargando…
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442088/ http://dx.doi.org/10.1186/1742-4690-9-S2-P365 |
| _version_ | 1782243431199801344 |
|---|---|
| author | Kwa, S Sadagopal, S Hong, J Gangadhara, S Basu, R Lai, L Iyer, S Araki, K Earl, PL Wyatt, L Villinger, F Moss, B Ahmed, R Amara, RR |
| author_facet | Kwa, S Sadagopal, S Hong, J Gangadhara, S Basu, R Lai, L Iyer, S Araki, K Earl, PL Wyatt, L Villinger, F Moss, B Ahmed, R Amara, RR |
| author_sort | Kwa, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3442088 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34420882012-09-18 CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections Kwa, S Sadagopal, S Hong, J Gangadhara, S Basu, R Lai, L Iyer, S Araki, K Earl, PL Wyatt, L Villinger, F Moss, B Ahmed, R Amara, RR Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3442088/ http://dx.doi.org/10.1186/1742-4690-9-S2-P365 Text en Copyright ©2012 Kwa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Kwa, S Sadagopal, S Hong, J Gangadhara, S Basu, R Lai, L Iyer, S Araki, K Earl, PL Wyatt, L Villinger, F Moss, B Ahmed, R Amara, RR CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title | CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title_full | CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title_fullStr | CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title_full_unstemmed | CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title_short | CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections |
| title_sort | cd40l adjuvant for dna/mva vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal siv infections |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442088/ http://dx.doi.org/10.1186/1742-4690-9-S2-P365 |
| work_keys_str_mv | AT kwas cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT sadagopals cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT hongj cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT gangadharas cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT basur cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT lail cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT iyers cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT arakik cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT earlpl cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT wyattl cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT villingerf cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT mossb cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT ahmedr cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections AT amararr cd40ladjuvantfordnamvavaccineenhancedprotectionfromacquisitionofneutralizationsensitiveneutralizationresistantmucosalsivinfections |